Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Gains from Investment Securities (2020 - 2025)

Bolt Biotherapeutics (BOLT) has disclosed Gains from Investment Securities for 6 consecutive years, with -$288000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 104.55% to -$288000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Sep 2025, up 9357.14% year-over-year, with the annual reading at $459775.0 for FY2025, 19.52% down from the prior year.
  • Gains from Investment Securities hit -$288000.0 in Q4 2025 for Bolt Biotherapeutics, down from $288000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $10.7 million in Q4 2023 to a low of -$288000.0 in Q4 2025.
  • Historically, Gains from Investment Securities has averaged $2.7 million across 5 years, with a median of $288000.0 in 2025.
  • Biggest five-year swings in Gains from Investment Securities: soared 94.15% in 2021 and later crashed 104.55% in 2025.
  • Year by year, Gains from Investment Securities stood at -$227000.0 in 2021, then skyrocketed by 983.26% to $2.0 million in 2022, then skyrocketed by 433.99% to $10.7 million in 2023, then crashed by 40.86% to $6.3 million in 2024, then plummeted by 104.55% to -$288000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for BOLT at -$288000.0 in Q4 2025, $288000.0 in Q1 2025, and $6.3 million in Q4 2024.